Abstract
Osteonecrosis of the jaws (ONJ) in osteoporosis patients has been defined as rare, but the number of reported cases is increasing. We report a case of delayed ONJ diagnosis in a patient, who was being treated with alendronate, developing bone alterations both in maxilla and in mandible. Underestimation of ONJ incidence and missed or delayed ONJ diagnosis in osteoporosis patients might derive from lack of awareness of health providers as well as from an ONJ definition that is too restricted. The more recent definition of medication-related osteonecrosis of the jaws (MRONJ) released in 2014 by the American Association of Oral Maxillofacial Surgeons (AAOMS) accept fistula, besides bone exposure, as a major sign of disease, but it seems to be insufficient since it excludes all cases of ONJ disease without bone exposure. A new MRONJ definition is needed to avoid missing or delayed diagnosis.
| Original language | English |
|---|---|
| Article number | 13 |
| Journal | Dentistry Journal |
| Volume | 5 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Mar 2017 |
Keywords
- Alendronate
- BRONJ
- Bisphosphonate
- Laser therapy
- MRONJ
- Osteonecrosis of jaw
- Osteoporosis
Fingerprint
Dive into the research topics of 'Osteonecrosis of the jaw (ONJ) in osteoporosis patients: Report of delayed diagnosis of a multisite case and commentary about risks coming from a restricted ONJ definition'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver